BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 28946890)

  • 1. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
    Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
    Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis.
    Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
    Immunol Cell Biol; 2014 Jul; 92(6):509-17. PubMed ID: 24638064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.
    Chuluundorj D; Harding SA; Abernethy D; La Flamme AC
    Immunol Cell Biol; 2017 Mar; 95(3):297-305. PubMed ID: 27694998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequencies of peripheral blood CD5
    Khani L; Jazayeri MH; Nedaeinia R; Bozorgmehr M; Nabavi SM; Ferns GA
    Allergy Asthma Clin Immunol; 2022 Jan; 18(1):5. PubMed ID: 35031055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Th17 cells in neuromyelitis optica spectrum disorder: a review.
    Lin J; Li X; Xia J
    Int J Neurosci; 2016 Dec; 126(12):1051-60. PubMed ID: 26954363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th2 axis-related cytokines in patients with neuromyelitis optica spectrum disorders.
    Zhang Y; Yao XY; Gao MC; Ding J; Hong RH; Huang H; Zhuang L; Wang YG; Hao Y; Guan YT
    CNS Neurosci Ther; 2018 Jan; 24(1):64-69. PubMed ID: 29110391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder.
    Hoshino Y; Noto D; Sano S; Tomizawa Y; Yokoyama K; Hattori N; Miyake S
    J Neuroinflammation; 2022 Jan; 19(1):6. PubMed ID: 34991631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder.
    Yamashita K; Kinoshita M; Miyamoto K; Namba A; Shimizu M; Koda T; Sugimoto T; Mori Y; Yoshioka Y; Nakatsuji Y; Kumanogoh A; Kusunoki S; Mochizuki H; Okuno T
    J Neuroinflammation; 2018 Apr; 15(1):125. PubMed ID: 29703264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated circulating CD14
    Peng A; Ke P; Zhao R; Lu X; Zhang C; Huang X; Tian G; Huang J; Wang J; Invernizzi P; Chen Q; Zhuang J
    Clin Exp Med; 2016 Nov; 16(4):511-521. PubMed ID: 26403460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychiatric comorbidities and suicidality among patients with neuromyelitis optica spectrum disorders in Argentina.
    Fernández VC; Alonso N; Melamud L; Villa AM
    Mult Scler Relat Disord; 2018 Jan; 19():40-43. PubMed ID: 29125969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pro-inflammatory phenotype of the human non-classical monocyte subset is attributed to senescence.
    Ong SM; Hadadi E; Dang TM; Yeap WH; Tan CT; Ng TP; Larbi A; Wong SC
    Cell Death Dis; 2018 Feb; 9(3):266. PubMed ID: 29449647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of IL-6
    Barros PO; Dias ASO; Kasahara TM; Ornelas AMM; Aguiar RS; Leon SA; Ruiz A; Marignier R; Araújo ACRA; Alvarenga R; Bento CAM
    J Neuroimmunol; 2017 Jun; 307():82-90. PubMed ID: 28495144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines and Tissue Damage Biomarkers in First-Onset Neuromyelitis Optica Spectrum Disorders: Significance of Interleukin-6.
    Wei Y; Chang H; Li X; Wang H; Du L; Zhou H; Xu W; Ma Y; Yin L; Zhang X
    Neuroimmunomodulation; 2018; 25(4):215-224. PubMed ID: 30544111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifaceted Defects in Monocytes in Different Phases of Chronic Hepatitis B Virus Infection: Lack of Restoration after Antiviral Therapy.
    Dey D; Pal S; Chakraborty BC; Baidya A; Bhadra S; Ghosh R; Banerjee S; Ahammed SKM; Chowdhury A; Datta S
    Microbiol Spectr; 2022 Dec; 10(6):e0193922. PubMed ID: 36445121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and Chemokine Profiles in Patients with Neuromyelitis Optica Spectrum Disorder.
    Wang Y; Zhou Y; Sun X; Lu T; Wei L; Fang L; Chen C; Huang Q; Hu X; Lu Z; Peng L; Qiu W
    Neuroimmunomodulation; 2016; 23(5-6):352-358. PubMed ID: 28445879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between serum levels of endothelin-1 and disease severity in patients with neuromyelitis optica spectrum disorders.
    Yi M; Liu MQ; Chou LS; Jiang SM; Zhang LJ; Huang CN; Wang N; Zhang QX; Yang L
    Immunobiology; 2020 May; 225(3):151959. PubMed ID: 32517881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perturbations of Monocyte Subsets and Their Association with T Helper Cell Differentiation in Acute and Chronic HIV-1-Infected Patients.
    Chen P; Su B; Zhang T; Zhu X; Xia W; Fu Y; Zhao G; Xia H; Dai L; Sun L; Liu L; Wu H
    Front Immunol; 2017; 8():272. PubMed ID: 28348563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans.
    Thaler B; Hohensinner PJ; Krychtiuk KA; Matzneller P; Koller L; Brekalo M; Maurer G; Huber K; Zeitlinger M; Jilma B; Wojta J; Speidl WS
    Sci Rep; 2016 Jul; 6():30162. PubMed ID: 27444882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology.
    Fujihara K; Bennett JL; de Seze J; Haramura M; Kleiter I; Weinshenker BG; Kang D; Mughal T; Yamamura T
    Neurol Neuroimmunol Neuroinflamm; 2020 Sep; 7(5):. PubMed ID: 32820020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.